This RSA section is an unofficial mirror, is not legal advice, and may be incomplete, outdated, or incorrectly processed.

RSA 326-B:11 · Scope of Practice and Authority; Advanced Practice Registered Nurse

326-B:11 Scope of Practice and Authority; Advanced Practice Registered Nurse. –

Copy link
I.

Advanced practice registered nursing shall consist of a combination of knowledge and skills acquired in basic nursing education. The APRN scope of practice, with or without compensation or personal profit, shall be limited to:

Copy link
(a)

Performing acts of advanced assessment, diagnosing, prescribing, selecting, administering, and providing therapeutic measures and treatment regimes;

Copy link
(b)

Obtaining consultation, planning, and implementing collaborative management, referral, or transferring the care of the client as appropriate; and

Copy link
(c)

Providing such functions for which the APRN is educationally and experientially prepared and which are consistent with standards established by a national credentialing or certification body recognized by the National Council of State Boards of Nursing and approved by the board in the appropriate APRN role and specialty.

Copy link
II.

An APRN shall practice within standards consistent with standards established by a national credentialing or certification body recognized by the National Council of State Boards of Nursing and approved by the board in the appropriate APRN role and specialty. The board shall not approve a new advanced practice specialty category that has not been developed by a national credentialing or certifying body recognized by the National Council of State Board of Nursing without approval of the legislature under RSA 332-G:6. Each APRN shall be accountable to clients and the board:

Copy link
(a)

For complying with this chapter and the quality of advanced nursing care rendered;

Copy link
(b)

For recognizing limits of knowledge and experience and planning for the management of situations beyond the APRN's expertise; and

Copy link
(c)

For consulting with or referring clients to other health care providers as appropriate.

Copy link
III.

An APRN shall have plenary authority to possess, compound, prescribe, administer, and dispense and distribute to clients controlled and non-controlled drugs within the scope of the APRN's practice as defined by this chapter. Such authority may be denied, suspended, or revoked by the board after notice and the opportunity for hearing, upon proof that the authority has been abused. III-a. An APRN licensed under this chapter may prescribe non-opioid and opioid controlled drugs classified in schedule II through IV by means of telemedicine. When prescribing a non-opioid or opioid controlled drug classified in schedule II through IV by means of telemedicine, a subsequent evaluation shall be conducted by a practitioner licensed to prescribe the drug at intervals appropriate for the patient, medical condition, and drug, but not less than annually. The prescription authority under this paragraph shall be limited to an APRN licensed under this chapter, and all prescribing shall be in compliance with all federal and state laws and regulations.

Copy link
IV.

Any expansion of the scope of practice shall be adopted by legislation in accordance with RSA 332-G:6. Source. 2005, 293:1. 2009, 54:3, 5, eff. July 21, 2009. 2019, 284:2, eff. July 19, 2019. 2025, 134:3, eff. Aug. 23, 2025.

Copy link

Source note

Source. 2005, 293:1. 2009, 54:3, 5, eff. July 21, 2009. 2019, 284:2, eff. July 19, 2019. 2025, 134:3, eff. Aug. 23, 2025.

Source history

  • 2005, 293:1
  • 2009, 54:3, 5, eff. July 21, 2009
  • 2019, 284:2, eff. July 19, 2019
  • 2025, 134:3, eff. Aug. 23, 2025

Related materials

Bill relationships

  • 2026 HB1321 reference

    cian licensed under this chapter, a physician associate licensed under RSA 328-D acting within the scope of their practice, or an advanced practice registered nurse licensed under RSA 326-B acting within the scope of their practice. 329:56 Administration of Elective Intravenous Therapy. Elective intravenous therapy may only be administered by a physician licensed under this chapter, a physician associ

  • 2026 HB1796 reference · effective 2027-01-01

    rgeon or osteopathic physician and surgeon licensed pursuant to RSA 329, a physician associate licensed pursuant to RSA 328-D, or an advanced practice registered nurse pursuant to RSA 326-B, who is registered by the department to recommend treatment with psilocybin. XX. “Qualified therapy provider” means a physician and surgeon or osteopathic physician and surgeon licensed pursuant to RSA 329, a physic

  • 2026 HB1796-FN reference · effective 2027-01-01

    rgeon or osteopathic physician and surgeon licensed pursuant to RSA 329, a physician associate licensed pursuant to RSA 328-D, or an advanced practice registered nurse pursuant to RSA 326-B, who is registered by the department to recommend treatment with psilocybin. XX. “Qualified therapy provider” means a physician and surgeon or osteopathic physician and surgeon licensed pursuant to RSA 329, a physic

  • 2026 SB453 reference

    d by the commissioner or his designee shall be for a period not to exceed 2 years; except in any case where a licensed physician, advanced practice registered nurse licensed under RSA 326-B, or physician associate licensed under RSA 329-D documents a lasting medical necessity, in which case the waiver shall be for a period not to exceed 4 years. The applicant may reapply for the waiver before such period e

  • 2025 HB254 reference

    tions to be used in medical aid in dying: (1) A physician licensed pursuant to RSA 329; (2) An osteopathic physician licensed pursuant to RSA 329; (3) An advanced practice registered nurse licensed pursuant to RSA 326-B; or (4) A pharmacist licensed pursuant to RSA 318; provided, however, that a pharmacist shall not qualify as an attending health care provider under RSA 137-M:1, II or as a consulting health care provider unde